The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
PD

p.diallo

TL2 Moderator · Uppsala

Contributes reviews on supplier material. Based in Uppsala.

Joined 21 January 2025 · last posted 3d

88Posts here
1Topics
1Solutions
341Likes received
352Likes given
23Badges
146Days visited
1.6kPosts read

Most-liked posts

  • [2026 update] Buffers, pH and why a formulation is a formulation Started this topic · Pharmacology › Formulation chemistry · 2 Feb 2026 · 35 likes Posting this under the heading it deserves: Buffers, pH and why a formulation is a formulation Everything below is what sits behind that. Working through the identity…
  • New subcategory: rationale and scope Replied, post #70 · Meta › Announcements · 20 Oct 2025 · 33 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
  • Which panel is worth repeating and which is worth ignoring Replied, post #39 · Clinical › Bloodwork · 15 Jun 2025 · 32 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
  • Run-in periods and the population they select Replied, post #54 · Evidence › Trials · 22 Jan 2026 · 31 likes Picking up post #51: that is the part I would want checked first. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass…
  • Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #39 · Compounds › Oral incretins · 11 Nov 2025 · 31 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
  • Stepping down deliberately, and how to do it without losing progress Replied, post #12 · Practice › Dosing & titration · 7 Nov 2025 · 30 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…

Where this member posts

CategoryPostsShare
Practice1315%
Compounds1214%
Evidence1113%
Analytics1011%
Sourcing1011%
Devices56%

Badges earned, in order

BadgeTierGranted
Basic Userbronze24 Jan 2025
Read the Guidelinesbronze24 Jan 2025
First Replybronze28 Jan 2025
Welcomebronze1 Feb 2025
First Topicbronze3 Feb 2025
Asked Wellbronze10 Feb 2025
First Linkbronze12 Feb 2025
First Quotebronze13 Feb 2025
First Tagbronze21 Feb 2025
Nice Postbronze2 Mar 2025
Sourcedbronze11 Mar 2025
Memberbronze12 Mar 2025
Generousbronze26 Mar 2025
Nice Topicbronze31 Mar 2025
Readerbronze20 Apr 2025
Good Postsilver27 Apr 2025
First Solutionbronze9 May 2025
Good Topicsilver3 Jun 2025
Editorbronze15 Jun 2025
First Vendor Reportbronze17 Jun 2025
Thank Yousilver6 Aug 2025
Anniversarysilver21 Jan 2026
De-escalatorgold7 Feb 2026